SIK2 and pulmonary fibrosis: Furthermore, the anti-fibrotic activity of ARN-3236 was blocked by the CREB inhibitor 666-15, indicating that inactivation of SIK2 might alleviate pulmonary fibrosis through CRTC2-mediated CREB pathway (Figs. 4, 5).